Evidence map›Paper›PMID 28167276›Full record

ArticleJournal of immunological methods2017

Detection and monitoring PLA

Peter D Burbelo, Laurence H Beck, Meryl Waldman

Abstract readComparative Study
In one paragraph

Article in Journal of immunological methods, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Perspectives in membranous nephropathy.Cell and tissue research · 2021
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Detection of PLA2R Autoantibodies before the Diagnosis of Membranous Nephropathy.Journal of the American Society of Nephrology : JASN · 2020
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Peter D BurbeloDental Clinical Research Core, NIDCR, NIH, Bethesda, MD, United States. Electronic address: burbelop@nidcr.nih.gov.
Laurence H BeckDepartment of Medicine, Section of Nephrology, Boston University School of Medicine, Boston, Mass, United States.
Meryl WaldmanKidney Disease Branch, NIDDK, NIH, Bethesda, MD, United States.
Boston University · USNational Institute of Dental and Craniofacial Research · USNational Institutes of Health · US

Funding

Redefining membranous nephropathy by autoantibody-specific subclassificationR01DK097053 · NIDDK · BOSTON MEDICAL CENTER · PI BECK, LAURENCE H · 2013 to 2017
$1.7M
Intramural NIH HHS Z99 DE999999NIDDK NIH HHS R01 DK097053
6 · The paper itself

Abstract

Autoantibodies against the M-type phospholipase A

Indexed as

AnimalsAutoantibodiesBiomarkersCase-Control StudiesChlorocebus aethiopsCOS CellsEnzyme-Linked Immunosorbent AssayGenes, ReporterGlomerulonephritis, MembranousHigh-Throughput Screening AssaysHumansImmunoassayImmunoprecipitationLuciferasesPredictive Value of TestsReceptors, Phospholipase A2AutoantibodiesBiomarkersLuciferasesReceptors, Phospholipase A2Recombinant Fusion Proteins

Identifiers

PMID28167276
PMCPMC5376496
OpenAlexW2583427269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.